Philipp L. Müller, Dr med, PD

Professor. Ophthalmologist. Retina specialist and clinician scientist at @Suedblick, @Moorfields Eye Hospital and @UniklinikBonn.

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

Delighted and honored to be appointed as apl. Professor at the University of Bonn. Grateful to everyone who has supported me along the way. Looking forward to continuing to contribute to research, education, and patient care.
#Ophthalmology #Research #UniversityOfBonn

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

I am sincerely grateful to my mentors, colleagues, collaborators, trainees, and my family for their unwavering support, trust, and encouragement throughout this journey.

It is a privilege to contribute to the advancement of ophthalmology.

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

Not the end of an inspiring journey at the Führungsakademie der DOG!
Over the past months, I had the privilege to learn, grow, and exchange ideas with an incredible group of p. This program has strengthened my skills and given me the chance to build many new friendship.

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

It was an honor to moderate and take part in this inspiring symposium at the DOG concerning the newest data and implications of real world studies.
Conferences are always a reminder of the importance of collaboration, innovation, and knowledge exchange in moving our field forward

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

On the way back from the annual meeting of the DOG 2025.

It was an honor to share the newest data of one of the largest real world studies with such an inspiring community of colleagues and experts in ophthalmology.

#DOG #ophthalmology #research #faricimab

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

Our landmark paper concerning the use of quantitative autofluorescence including predicting parameters, reliability, and sample size calculation is available online at https://t.co/5FqABglVNy
@Moorfields @UniklinikBonn @RetinaDiscovery @YoungRetina @BJOphthalmology

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

I was honoured to speak at the #EURETINA2022 conference today about the results of our study on quantitative autofluorescence. Thank you @EURETINA !

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

How common is common?
New insights into Macular Curvature and Dome-Shaped Configuration based on data from the unique UK Biobank. This may open new fields to future #myopia and #macula research! @RetinaDiscovery https://t.co/b8kn8gm4pT

[Roy Schwartz, MD, PhD @royschwartz]

📣I'm delighted to report that our paper describing the first #AI framework to identify and quantify drusen and #RPD on OCT scans is now in preprint! @RetinaDiscovery @uk_biobank @Moorfields @MoorfieldsBRC @cdt_ai_health
https://t.co/1kfVyYJm1Y

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

Great work that shows the importance of continued patient care during a pandemic.

[Abraham Olvera @abraham_olvera1]

Now published:
Estimating excess visual loss from neovascular age-related macular degeneration in the UK during the COVID-19 pandemic: a retrospective clinical audit and simulation model https://t.co/EA25VmGW0f
Well done @AlasdairWarwick, Darren Thomas. @RetinaDiscovery

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

The basis of #AI is reliability of the human gold standard. Check this out for features associated with #AMD. A further step into solving the riddle of retinal diseases. #fightingblindness

https://t.co/daBzAtV7sA

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

A great pleasure to present Paper #2 to predict function based on structure and demographics using #MachineLearning #AI . This might be a further step into future diagnostics.

https://t.co/mXY3e4pT0X
@JCM_MDPI @RetinaDiscovery

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

A great pleasure to present Paper #1 to predict function based on structure and demographics using #MachineLearning #AI . This might be a further step into future diagnostics.
https://t.co/MWhXUJ2yrA

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

Honoured to have participated in this study investigating the application of #AI in retinal diseases. Worth reading!

Quantification of key retinal features in early and late age-related macular degeneration using deep learning https://t.co/Knnh6WUdn9
@RetinaDiscovery

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

I am honoured to announce that our landmark paper on genetic, demographic, imaging and functional association of #lipofuscin accumulation is now available with a 50 days' free access to the article. Enjoy it! https://t.co/B5dATnbEGT

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

@lyubomirvladim5 @elonmusk

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

Our review of #OCTA application in geographic atrophy secondary to #AMD is now available. An innovative instrument that allows more insights into a common cause of blindness.
#fightingblindness https://t.co/5fWMgMuWDY @KargerPublisher @RetinaDiscovery @Moorfields @UniklinikBonn

[American Journal of Ophthalmology @AJOphthalmology]

@Moorfields with a great paper on atrophy in Maternally Inherited Deafness and Diabetes. This can mimic age related macular degeneration.

https://t.co/m86vtXVFEU

#retina #Ophthalmology #optometry #medicine

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

I am glad to announce that our novel review article for #OCTA application and limitation for #GA secondary #AMD is now available online at Ophthalmologica and worth reading. An emerging field for an innovative imaging device.
https://t.co/5fWMgMuWDY @KargerPublisher

[Philipp L. Müller, Dr med, PD @PhilippLMuller]

Was honoured to present the initial results of our #MIDD research at #Euretina2020. Hopefully this clean model disease help solve the #AMD and #aging riddle.
@EURETINA @YoungRetina @RetinaDiscovery